Using fluorescence technology in thyroid surgery
A Prospective , Controlled, Randomized Multi-center Study on the Usefulness of Fluorescence in Thyroid Surgery
This study tests if using special fluorescence technology during thyroid surgery can help doctors find and protect important glands, reducing the chance of complications after surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 260 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia Academic / other |
| Locations | 1 site (Murcia) |
| Trial ID | NCT06011369 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of fluorescence technology in thyroid surgery to enhance the identification and preservation of parathyroid glands, thereby reducing the risk of postoperative hypoparathyroidism. It involves a randomized approach where patients undergoing total thyroidectomy with or without lymph node dissection will be assigned to receive either standard surgical techniques or those enhanced with cervical fluorescence. The study aims to evaluate various clinical variables to determine the advantages of using fluorescence during the procedure.
Who should consider this trial
Good fit: Ideal candidates are adults undergoing total thyroidectomy with or without lymph node dissection.
Not a fit: Patients under 18 years of age or those undergoing hemithyroidectomy or reintervention of thyroid surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of postoperative complications related to parathyroid gland damage.
How similar studies have performed: Other studies have shown promising results with fluorescence technology in surgical settings, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Total thyroidectomy with/without lymph node dissection * Signature of informed consent Exclusion Criteria: * Patients under 18 years of age * Hemithyroidectomy * Reintervention of thyroid surgery
Where this trial is running
Murcia
- Hospital Clínico Universitario Virgen de la Arrixaca — Murcia, Spain (Recruiting)
Study contacts
- Principal investigator: Beatriz Febrero, MD — Hcuva
- Study coordinator: Beatriz Febrero, MD
- Email: beatriz.febrero@um.es
- Phone: 968 36 95 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.